An Orally Defect-Rich MoO 3– x Nanozyme Enhances ROS Scavenging for Inflammatory Bowel Disease Therapy
ACS Applied Materials & Interfaces · 06.05.2026 · 18 (17) · 24262-24277
DOI: 10.1021/acsami.6c03483 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 27.04.2026. Verfasst von Fang-Jun Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Key Laboratory of Qinling Ecological Security, Shaanxi Key Laboratory for Animal Conservation, Shaanxi Institute of Zoology, Xi'an, Shaanxi 7…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Reactive Oxygen Species, Molybdenum, Oxides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Shaanxi Academy of Sciences, Xi'an Municipal Bureau of Science and Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), a gastrointestinal inflammatory ailment, presents substantial therapeutic hurdles. These challenges primarily arise from the excessive generation of reactive oxygen species (ROS) and the lack of targeted treatment strategies. To address this, ultrasmall and defect-rich MoO3-x nanozymes were fabricated through a simple liquid-phase synthesis method for boosting ROS scavenging in the treatment of inflammatory bowel disease. More specifically, the as-prepared MoO3-x nanozymes with multivalent states and oxygen vacancies not only curtail the levels of proinflammatory cytokines and showcase notable antibacterial effects but also display catalase- and superoxide dismutase-like activities, along with hydroxyl radical scavenging properties, making them more efficient in scavenging ROS than noncatalytic antioxidants. Moreover, the greater the amount of ligands, the more excellent the nanoenzyme activity. The optimized MoO3-x (-200) nanozymes exhibited stability in the gastric environment, making them suitable for oral delivery. In a murine model of IBD, these nanozymes alleviated colonic inflammation by reducing the levels of proinflammatory factors and myeloperoxidase (MPO) activity in colon tissues. Importantly, no significant systemic exposure was observed throughout the treatment. Furthermore, 16S rRNA sequencing analysis revealed that MoO3-x (-200) nanozyme intervention partially modulated the composition of gut microbiota in mice with colitis, specifically promoting the augmentation of advantageous bacterial communities. This study offers novel perspectives regarding the advancement of highly effective oral formulations for the treatment of inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shaanxi Key Laboratory of Qinling Ecological Security, Shaanxi Key Laboratory for Animal Conservation, Shaanxi Institute of Zoology, Xi'an, Shaanxi 710072, P. R. China.
- Life sciences College, Luoyang Normal University, Luo'yang, Henan 471934, P. R. China.
ORCID-Profile: Bin Yang
Förderung
- Shaanxi Academy of Sciences
- Xi'an Municipal Bureau of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Cao, F. J., Feng, H., Jin, T. Z., Yang, W. P., & Yang, B. (2026). An Orally Defect-Rich MoO 3– x Nanozyme Enhances ROS Scavenging for Inflammatory Bowel Disease Therapy. ACS Applied Materials & Interfaces, 18(17), 24262-24277. https://doi.org/10.1021/acsami.6c03483
Vancouver
Cao FJ, Feng H, Jin TZ, Yang WP, Yang B. An Orally Defect-Rich MoO 3– x Nanozyme Enhances ROS Scavenging for Inflammatory Bowel Disease Therapy. ACS Applied Materials & Interfaces. 2026;18(17):24262-24277. doi:10.1021/acsami.6c03483
BibTeX
@article{Cao2026,
author = {Cao, Fang-Jun and Feng, Hui and Jin, Tie-Zhi and Yang, Wei-Ping and Yang, Bin},
title = {An Orally Defect-Rich MoO 3– x Nanozyme Enhances ROS Scavenging for Inflammatory Bowel Disease Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {17},
pages = {24262--24277},
doi = {10.1021/acsami.6c03483}
}
EUVIMED